South Africa: GlaxoSmithKline, Boehringer Ingelheim "Abused Monopoly"
South Africa's Competition Commission ruled that GlaxoSmithKline South Africa and Boehringer Ingelheim abused their monopoly positions by refusing to license antiretroviral drugs to combat HIV and AIDS to generics makers in...To view the full article, register now.
Already a subscriber? Click here to view full article